Delivery Order SPE2DB22D2006-SPE2DB24FV7AV
Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $100K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $111,931.56 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4557485564 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. This order was placed under an indefinite delivery contract held by AmerisourceBergen to provide pharmaceuticals, medical supplies, and related distribution services to support DLA Troop Support Medical programs. The order has a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The $78,864.00 contract has a completion date of January 9, 2024 and was awarded on January 8, 2024. AmerisourceBergen Drug Corp is a for-profit organization that serves as a prime contractor to supply pharmaceuticals, medical supplies, and related distribution...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The $5,030.83 order supports DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceuticals, medical supplies, and distribution services to U.S. government agencies, primarily the Department of Defense. This delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes. The order has a potential value of $103,308.00 and a completion date of November 1, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards to provide pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a $72,453.28 delivery order to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes, with an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside structure. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,559.94 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes. This non-competitive delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a firm fixed-price purchase of hepatitis B vaccine syringes to support federal medical supply needs. The award was fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The order has a completion date of February 8, 2024 and a potential value of $1,577.28. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Additionally, Amerisourcebergen Drug Corp holds...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,684.96 to supply HEPLISAV-B 20 mcg/0.5 mL syringes on May 27, 2025. The order is a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award does not utilize a set-aside designation and was competitively awarded. This delivery order is a child contract under...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HEPLISAV-B 20 MCG/0.5 ML syringes. The $113,046.95 contract has a completion date of March 31, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,148.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical product. The contract has an ultimate completion date of March 25, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31,...